Abbott Laboratories (ABT) Finished Goods (2009 - 2026)

Abbott Laboratories has disclosed Finished Goods across 18 years of filings, most recently posting $4.5 billion for Q2 2026.

• In Q2 2026, Finished Goods rose 4.47% year-over-year to $4.5 billion; the TTM figure through Jun 2026 stood at $4.5 billion (up 4.47% YoY), while the FY2025 annual figure was $4.0 billion, up 7.46% from the prior year.
• Finished Goods came in at $4.5 billion for Q2 2026 at Abbott Laboratories, up from $4.3 billion in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $4.5 billion in Q2 2026 to a low of $3.4 billion in Q3 2022.
• Average Finished Goods over 5 years is $4.0 billion, with a median of $4.0 billion recorded in 2023.
• Year-over-year, Finished Goods gained 23.5% in 2022 and declined 6.23% in 2024.
• Over 5 years, Finished Goods stood at $3.8 billion in 2022, then increased by 3.71% to $3.9 billion in 2023, then slipped by 6.23% to $3.7 billion in 2024, then increased by 7.46% to $4.0 billion in 2025, then climbed by 13.48% to $4.5 billion in 2026.
• Per Business Quant data, the three most recent Finished Goods figures were $4.5 billion in Q2 2026, $4.3 billion in Q1 2026, and $4.0 billion in Q4 2025.